Results 261 to 270 of about 306,885 (363)

Patient Satisfaction and Resource Utilization Following Introduction of Long-Acting Injectable Buprenorphine (LAIB) in Scottish Prisons. [PDF]

Subst Abuse Rehabil
Sayers C, Mogford D.
europepmc   +1 more source

Lawyer CEOs and Strategic Disclosure of Litigation Loss Contingencies

Abacus, EarlyView.
Using hand‐collected data, we find that lawyer CEOs, defined as CEOs with a legal education background, tend to make first disclosures about pending litigation cases on a timelier basis for litigation cases that end up with material losses than do non‐lawyer CEOs.
Feng Chen, Yu Hou, Gordon Richardson, Barbara Su   +3 more
wiley   +1 more source

Social capital and COVID-19 vaccination in prisons: a survey of attitudes, beliefs, and motivations. [PDF]

J Public Health (Oxf)
Perrett SE, Thomas DR, Saville CWN.
europepmc   +1 more source

Risk Assessment in New Zealand Prisons: Questioning Experiential Outcomes

, 1969
Daniel Luff, Greg Newbold
openalex   +2 more sources

Recovery support services as part of the continuum of care for alcohol or drug use disorders

Addiction, EarlyView.
Abstract Background The definition of ‘recovery’ has evolved beyond merely control of problem substance use to include other aspects of health and wellbeing (known as ‘recovery capital’) which are important to prevent relapse to problematic alcohol or other drug (AOD) use.
Ed Day, Laura Charlotte Pechey, Suzie Roscoe, John F. Kelly   +3 more
wiley   +1 more source

Tuberculosis Screening before Anti–Hepatitis C Virus Therapy in Prisons

Emerging Infectious Diseases, 2012
Sergio Babudieri, Andrea Soddu, Monica Murino, Paola Molicotti, Alberto A. Muredda, Giordano Madeddu, Alessandro G. Fois, Stefania Zanetti, Pietro Pirina, Maria Stella Mura   +9 more
doaj   +1 more source

Prison categorization policy in the United Kingdom. [PDF]

Front Sociol
Thomas S, Glazzard J.
europepmc   +1 more source

Pains of Imprisonment, Everyday Deprivation and the Meanings of Post-Prison

, 1969
Kevin Walby
openalex   +2 more sources

Extended‐release pharmacotherapies for substance use disorders in incarcerated populations: A systematic review

Addiction, Volume 120, Issue 5, Page 835-859, May 2025.
Abstract Background and aims Substance use (SU) is prevalent among individuals in the criminal justice system (CJS). However, there is often poor access to treatment. We aimed to assess the effectiveness of two medications, extended‐release naltrexone (XR‐NTX) and extended‐release buprenorphine (XR‐BUP) for the prison population.
Amelia Woods, Catherine Foley, Katherine M. Conigrave, Winifred Asare‐Doku, Anthony Shakeshaft, Stella Settumba‐Stolk, Michael Farrell, Michael Doyle   +7 more
wiley   +1 more source

Cardiovascular Disease in Women's Prisons: A Qualitative Study of Dietary Habits from the Perspective of Professionals. [PDF]

Nutrients
Machado AM, Ferreira IR, Rodrigues M, Taveira A, Linhares F, Macedo AP.   +5 more
europepmc   +1 more source